HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyo Song Kim Selected Research

SAR125844

10/2017Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hyo Song Kim Research Topics

Disease

42Neoplasms (Cancer)
05/2024 - 02/2009
40Stomach Neoplasms (Stomach Cancer)
05/2024 - 01/2007
11Sarcoma (Soft Tissue Sarcoma)
01/2024 - 03/2012
8Renal Cell Carcinoma (Grawitz Tumor)
10/2016 - 06/2009
6Neoplasm Metastasis (Metastasis)
05/2024 - 01/2007
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2019 - 01/2009
4Aggressive Fibromatosis (Desmoid)
02/2024 - 01/2021
4Disease Progression
02/2024 - 05/2009
4Neutropenia
01/2024 - 06/2009
4Liposarcoma
01/2022 - 06/2009
4Esophageal Squamous Cell Carcinoma
10/2020 - 06/2008
4Adenocarcinoma
01/2018 - 01/2007
3Fatigue
10/2022 - 06/2013
3Leiomyosarcoma
01/2022 - 03/2015
3Breast Neoplasms (Breast Cancer)
09/2017 - 11/2009
3Anemia
10/2013 - 01/2007
2Microsatellite Instability
10/2023 - 01/2020
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2022 - 05/2022
2Hemangiosarcoma (Angiosarcoma)
03/2021 - 01/2019
2Synovial Sarcoma (Synovioma)
01/2019 - 03/2015
2Melanoma (Melanoma, Malignant)
10/2015 - 04/2010
2Rhabdomyosarcoma
03/2015 - 01/2014
2Thrombocytopenia (Thrombopenia)
10/2013 - 01/2007
2Carcinoma (Carcinomatosis)
12/2010 - 02/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2010 - 05/2009
1Thrombocytopenia 4
01/2024
1Diarrhea
10/2022
1Constipation
10/2022

Drug/Important Bio-Agent (IBA)

16Biomarkers (Surrogate Marker)IBA
10/2023 - 07/2009
8Trastuzumab (Herceptin)FDA Link
01/2023 - 01/2016
7Cisplatin (Platino)FDA LinkGeneric
01/2019 - 06/2008
6Paclitaxel (Taxol)FDA LinkGeneric
04/2024 - 10/2015
6pazopanibFDA Link
01/2024 - 03/2015
6Tyrosine Kinase InhibitorsIBA
01/2024 - 07/2009
6Docetaxel (Taxotere)FDA Link
01/2019 - 01/2009
5Immune Checkpoint InhibitorsIBA
09/2023 - 06/2017
5Proteins (Proteins, Gene)FDA Link
12/2022 - 05/2009
5Phosphotransferases (Kinase)IBA
11/2022 - 11/2016
5Capecitabine (Xeloda)FDA Link
04/2019 - 06/2008
4ErbB Receptors (EGF Receptor)IBA
10/2023 - 07/2009
4GemcitabineFDA Link
01/2022 - 05/2009
4Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2019 - 07/2009
4Sunitinib (Sutent)FDA Link
10/2013 - 06/2009
3DNA (Deoxyribonucleic Acid)IBA
04/2023 - 05/2009
3human ERBB2 proteinIBA
01/2023 - 03/2018
3tyrosine receptor (receptor, tyrosine)IBA
05/2022 - 11/2016
3EverolimusFDA Link
10/2016 - 10/2013
3PlatinumIBA
10/2015 - 01/2009
3Irinotecan (Camptosar)FDA LinkGeneric
10/2011 - 05/2009
2Imatinib Mesylate (Gleevec)FDA Link
02/2024 - 10/2022
2Alanine Transaminase (SGPT)IBA
01/2024 - 06/2009
2NivolumabIBA
10/2023 - 10/2023
2AfatinibIBA
10/2023 - 10/2020
2TropomyosinIBA
11/2022 - 05/2022
2RNA (Ribonucleic Acid)IBA
10/2022 - 06/2017
2CateninsIBA
10/2022 - 01/2021
2B7-H1 AntigenIBA
01/2020 - 04/2019
2CytokinesIBA
10/2019 - 03/2010
2Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 06/2008
2Formaldehyde (Formol)FDA Link
06/2017 - 03/2016
2ParaffinIBA
06/2017 - 03/2016
2Alkaline PhosphataseIBA
06/2017 - 01/2007
2CreatinineIBA
10/2016 - 06/2009
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
02/2016 - 02/2009
2Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
06/2015 - 02/2015
2IfosfamideFDA LinkGeneric
03/2014 - 03/2012
2Pemetrexed (MTA)FDA Link
10/2013 - 01/2009
2CatecholaminesIBA
06/2008 - 12/2007
1vactosertibIBA
02/2024
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2024
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2024
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2024
1durvalumabIBA
01/2024
1Anti-Bacterial Agents (Antibiotics)IBA
11/2023
1GSK2636771IBA
10/2023
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2023
1TensinsIBA
10/2023
1VaccinesIBA
06/2023
1P-2 (P 2)IBA
04/2023
1RamucirumabIBA
01/2023
1beta CateninIBA
12/2022
1HLA-B Antigens (HLA-B)IBA
10/2022
1pembrolizumabIBA
10/2022
1BiguanidesIBA
10/2022
1Lactic Acid (Lactate)FDA LinkGeneric
10/2022

Therapy/Procedure

32Drug Therapy (Chemotherapy)
05/2024 - 06/2008
19Therapeutics
02/2024 - 01/2007
8Gastrectomy
04/2019 - 01/2016
7Adjuvant Chemotherapy
04/2019 - 01/2015
6Radiotherapy
02/2024 - 10/2009
5Combination Drug Therapy (Combination Chemotherapy)
10/2013 - 07/2009
3Precision Medicine
07/2023 - 01/2020
3Neoadjuvant Therapy
01/2018 - 12/2016
2Chemoradiotherapy
11/2019 - 01/2010
2Immunotherapy
01/2018 - 10/2009
2Adjuvant Radiotherapy
03/2017 - 06/2009
1Hyperthermic Intraperitoneal Chemotherapy
05/2024
1Cytoreduction Surgical Procedures
05/2024
1Hospice Care (Care, Bereavement)
01/2023
1Palliative Care (Palliative Therapy)
01/2023